ki 1769 has been researched along with Muscle Relaxation in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Izawa, T; Izumi, H; Kasai, H; Ogawa, N; Okada, Y; Yokoyama, T | 1 |
| Izawa, T; Izumi, H; Kawahara, J; Ogawa, N; Takeuchi, A | 1 |
2 other study(ies) available for ki 1769 and Muscle Relaxation
| Article | Year |
|---|---|
Effect of Kil769, a novel K(+)-channel opener, on sensitivity to Ca2+ of contractile elements and inositol phosphate formation in porcine coronary artery.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Calcium; Calcium Channel Blockers; Coronary Vessels; Dose-Response Relationship, Drug; Fura-2; Glyburide; Hydrolysis; In Vitro Techniques; Inositol Phosphates; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Potassium Channels; Prostaglandin Endoperoxides, Synthetic; Pyridines; Swine; Thromboxane A2; Vasoconstrictor Agents; Vasodilator Agents; Verapamil | 1995 |
In vitro and in vivo vasodilating effects of KRN4884, Ki1769 and Ki3005, pyridinecarboxamidine derivatives.
Topics: Animals; Antihypertensive Agents; Aorta, Thoracic; Blood Pressure; Disease Models, Animal; Dose-Response Relationship, Drug; Glyburide; Heart Rate; Hypertension; In Vitro Techniques; Injections, Intravenous; Male; Muscle Relaxation; Muscle, Smooth, Vascular; Potassium Channels; Pyridines; Rats; Rats, Wistar; Structure-Activity Relationship; Vasodilator Agents | 1997 |